348P A national plan of action to raise awareness and improve medical care of Duchenne muscular Dystrophy (AIM-DMD)
Gülçin Akıncı(Izmir University), Haluk Topaloğlu(Yeditepe University), Mustafa Kömür(Mersin Üniversitesi), Adem Coskun(Ankara Atatürk Eğitim ve Araştırma Hastanesi), Tuncay Derya Okur(Dokuz Eylül University), Özlem Yayıcı Köken(Akdeniz University), C. Ayanoglu(Yeditepe University), H. Bektas Ontas(Ankara University), Uluç Yiş(Dokuz Eylül University), E. Ontas(Ankara University), Deniz Yüksel(Turkish Armed Forces)
Cited by 0
Related Papers
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy
|Nature Genetics|2009|256
Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy
|Nature Genetics|2005|251
Mutations in KLHL40 Are a Frequent Cause of Severe Autosomal-Recessive Nemaline Myopathy
|The American Journal of Human Genetics|2013|224